Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)

Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)

Frontotemporal lobar degeneration (FTLD) defines a spectrum of heterogeneous neurodegenerative disorders characterized by the progressive deterioration of the frontal and anterior temporal lobes of the brain. FTLD is histopathologically classified according to the presence of neuropathological prote...

Full description

Bibliographic Details
Main Authors:	Guinevere F. Lourenco, Michael Janitz, Yue Huang, Glenda M. Halliday
Format:	Article
Language:	English
Published:	Elsevier 2015-10-01
Series:	Neurobiology of Disease
Subjects:	Frontotemporal lobar degeneration TDP-43 FUS/TLS Long noncoding RNA Neurodegeneration
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996115300164

Similar Items

Neuropathology of frontotemporal lobar degeneration: A review
by: Valéria Santoro Bahia, et al.

Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
by: Shunsuke Koga, et al.
Published: (2023-07-01)

Neuronal intermediate filament inclusion disease may be incorrectly classified as a subtype of FTLD-FUS
by: Kevin F Bieniek, et al.
Published: (2020-03-01)

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
by: Sarah Pickles, et al.
Published: (2022-07-01)

Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations
by: Kocerha Jannet, et al.
Published: (2011-10-01)

Molecular Pathways Involved in Frontotemporal Lobar Degeneration with TDP-43 Proteinopathy: What Can We Learn from Proteomics?
by: Merel O. Mol, et al.
Published: (2021-09-01)

Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration
by: Ahmed Yousef, et al.
Published: (2017-09-01)

Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors
by: Luigi Fiondella, et al.
Published: (2023-04-01)

Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration
by: Alba Cervantes González, et al.
Published: (2022-04-01)

The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
by: Britt A. Berning, et al.
Published: (2019-04-01)

The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons
by: Daiyu Honda, et al.
Published: (2014-01-01)

Frontotemporal Lobar Degeneration and microRNAs
by: Paola ePiscopo, et al.
Published: (2016-02-01)

Alterations in stress granule dynamics driven by TDP-43 and FUS: A link to pathological inclusions in ALS?
by: Anais eAulas, et al.
Published: (2015-10-01)

Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS
by: Lauren M. Gittings, et al.
Published: (2019-02-01)

Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD
by: Alistair Wood, et al.
Published: (2021-04-01)

New Perspective on Parkinsonism in Frontotemporal Lobar Degeneration
by: Hee Kyung Park, et al.
Published: (2013-04-01)

Experimental Disease-Modifying Agents for Frontotemporal Lobar Degeneration
by: Giunta M, et al.
Published: (2021-03-01)

Genetics of frontotemporal lobar degeneration
by: Aswathy P, et al.
Published: (2010-10-01)

Cerebrospinal Fluid TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis Patients with and without the C9ORF72 Hexanucleotide Expansion
by: Anna Junttila, et al.
Published: (2016-04-01)

Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
by: Rachel H. Tan, et al.
Published: (2023-11-01)

Therapeutic and diagnostic challenges for frontotemporal dementia
by: Simon eD'Alton, et al.
Published: (2014-08-01)

Transcriptomopathies of pre- and post-symptomatic frontotemporal dementia-like mice with TDP-43 depletion in forebrain neurons
by: Lien-Szu Wu, et al.
Published: (2019-03-01)

Pharmacological treatment of frontotemporal lobar degeneration: systematic review Tratamento farmacológico da degeneração lobar frontotemporal: revisão sistemática
by: Maria da Glória Portugal, et al.
Published: (2011-03-01)

Extended FTLD pedigree segregating a Belgian GRN-null mutation: neuropathological heterogeneity in one family
by: Anne Sieben, et al.
Published: (2018-01-01)

Neuronal cytoplasmic inclusions in tau, TDP-43, and FUS molecular subtypes of frontotemporal lobar degeneration share similar spatial patterns
by: Richard A. Armstrong
Published: (2017-09-01)

Endogenous TDP-43, but not FUS, contributes to stress granule assembly via G3BP
by: Aulas Anaïs, et al.
Published: (2012-10-01)

Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype
by: Kasper Katisko, et al.
Published: (2022-10-01)

Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration
by: Ione O. C. Woollacott, et al.
Published: (2020-08-01)

Co-Occurrence of Language and Behavioural Change in Frontotemporal Lobar Degeneration
by: Jennifer M. Harris, et al.
Published: (2016-06-01)

Underdiagnosis of frontotemporal lobar degeneration in Brazil
by: Valéria Santoro Bahia

Genetics of Frontotemporal Lobar Degeneration
by: Daniela eGalimberti, et al.
Published: (2012-04-01)

Editorial: The role of gene mutations in the neuropathology of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD)– Progress and challenges
by: Claire Troakes, et al.
Published: (2023-02-01)

The Role of TDP-43 in Military-Relevant TBI and Chronic Neurodegeneration
by: Lanier Heyburn, et al.
Published: (2019-06-01)

Regional and hemispheric susceptibility of the temporal lobe to FTLD-TDP type C pathology
by: V. Borghesani, et al.
Published: (2020-01-01)

Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies
by: Laetitia Miguel, et al.
Published: (2011-02-01)

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
by: Garrett S. Gibbons, et al.
Published: (2019-03-01)

TDP-43 mislocalization drives neurofilament changes in a novel model of TDP-43 proteinopathy
by: Rachel Atkinson, et al.
Published: (2021-02-01)

Event-based modeling of T1-weighted MRI is related to pathology in frontotemporal lobar degeneration due to tau and TDP
by: Christopher A. Olm, et al.
Published: (2023-01-01)

Contribution of RNA/DNA Binding Protein Dysfunction in Oligodendrocytes in the Pathogenesis of the Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration Spectrum Diseases
by: Chiara F. Valori, et al.
Published: (2021-09-01)

HnRNP Pathologies in Frontotemporal Lobar Degeneration
by: Xinwa Jiang, et al.
Published: (2023-06-01)